Key result
Non-invasive decision algorithms integrating clinical features, biomarkers, and multimodality imaging are needed to differentiate giant cell myocarditis from cardiac sarcoidosis.
Highlights the need for non-invasive decision algorithms integrating clinical features, biomarkers, and imaging to differentiate between giant cell myocarditis and cardiac sarcoidosis.
Giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare inflammatory myocardial diseases associated with substantial morbidity and mortality [1]. While GCM primarily represents a fulm...
No takes yet. Share an insight, caveat, or question.
Bobbio et al. (2026) studied this question. Non-invasive decision algorithms integrating clinical features, biomarkers, and multimodality imaging are needed to differentiate giant cell myocarditis from cardiac sarcoidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: